Alpine Associates Management’s ChemoCentryx, Inc. CCXI Stock Holding History

Alpine Associates Management’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-455,000	Closed	-$23.5M	–	52
2022 Q3	$23.5M	Buy	+455,000	New	+$18.8M	0.98%	31

Other funds holding CCXI

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Alpine Associates Management's CCXI Position: Q4 2022 in Review

Alpine Associates Management sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 455,000 shares — an estimated $23.5M sold.

Alpine Associates Management first reported a position in CCXI in Q3 2022 and held it in 1 quarter. The position peaked at $23.5M in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

Alpine Associates Management reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
Alpine Associates Management sold 455,000 ChemoCentryx, Inc. shares in Q4 2022, an estimated $23.5M.
Alpine Associates Management first reported a position in ChemoCentryx, Inc. in Q3 2022 and held it in 1 quarter.
Alpine Associates Management's ChemoCentryx, Inc. position peaked at $23.5M in Q3 2022.
1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Alpine Associates Management's 13F filing for Q4 2022, filed 8 Feb 2023.